Replimune Group, Inc. - Common Stock, $0.001 par value (REPL)

CUSIP: 76029N106

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
82,661,978
Total 13F shares
70,902,356
Share change
+3,912,517
Total reported value
$638,102,295
Put/Call ratio
107%
Price per share
$9.00
Number of holders
148
Value change
+$37,351,096
Number of buys
85
Number of sells
71

Security key

76029N106

Report period

Q2 2024

Institutions

148

Top holders

10

Top shareholders of REPL - Replimune Group, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Omega Fund IV, L.P.
3/4/5
10%+ Owner
mixed-class rows
9,453,260
mixed-class rows
$103,049,420 14 Mar 2022
BAKER BROS. ADVISORS LP
13F
Company
12%
9,545,336
$77,985,395 31 Mar 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
7.9%
6,548,930
$53,505,000 31 Mar 2024
13F
STATE STREET CORP
13F
Company
7.8%
6,486,696
$52,996,306 31 Mar 2024
13F
FCPM III SERVICES B.V.
13F
Company
5.9%
4,866,449
$39,758,888 31 Mar 2024
13F
BlackRock Finance, Inc.
13F
Company
5.6%
4,612,558
$37,684,599 31 Mar 2024
13F
Redmile Group, LLC
13F
Company
4.5%
3,729,983
$30,473,961 31 Mar 2024
13F
Omega Fund Management, LLC
13F
Company
3.6%
3,001,319
$24,520,776 31 Mar 2024
13F
VANGUARD GROUP INC
13F
Company
3.4%
2,770,328
$22,633,579 31 Mar 2024
13F
Camber Capital Management LP
13F
Company
3.3%
2,750,000
$22,468,000 31 Mar 2024
13F
MORGAN STANLEY
13F
Company
3.2%
2,654,034
$21,683,458 31 Mar 2024
13F
Atlas Venture Life Science Advisors, LLC
13F
Company
2.5%
2,098,300
$17,143,111 31 Mar 2024
13F
Robert Coffin
3/4/5
Director
class O/S missing
1,821,872
$11,787,512 16 May 2024
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.4%
1,191,793
$9,738,654 31 Mar 2024
13F
Jefferies Financial Group Inc.
13F
Company
1.2%
1,000,000
$8,170,000 31 Mar 2024
13F
D. E. Shaw & Co., Inc.
13F
Company
1.2%
997,786
$8,151,912 31 Mar 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
1.2%
977,852
$7,989,050 31 Mar 2024
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
0.97%
802,984
$6,560,379 31 Mar 2024
13F
Ghost Tree Capital, LLC
13F
Company
0.79%
650,000
$5,310,500 31 Mar 2024
13F
Rafferty Asset Management, LLC
13F
Company
0.78%
642,078
$5,245,777 31 Mar 2024
13F
Colin Love
3/4/5
Chief Operating Officer
class O/S missing
777,345
$5,029,422 16 May 2024
CITIGROUP INC
13F
Company
0.66%
542,489
$4,432,135 31 Mar 2024
13F
DEUTSCHE BANK AG\
13F
Company
0.63%
522,046
$4,265,116 31 Mar 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.62%
513,340
$4,193,988 31 Mar 2024
13F
EMERALD ADVISERS, LLC
13F
Company
0.6%
492,219
$4,021,429 31 Mar 2024
13F
NORTHERN TRUST CORP
13F
Company
0.59%
483,644
$3,951,371 31 Mar 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.56%
461,862
$3,773,413 31 Mar 2024
13F
NORGES BANK
13F
Company
0.56%
459,900
$3,757,383 31 Mar 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.51%
418,664
$3,420,485 31 Mar 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.47%
390,031
$3,186,552 31 Mar 2024
13F
UBS Group AG
13F
Company
0.45%
367,986
$3,006,446 31 Mar 2024
13F
Pamela Esposito
3/4/5
Chief Business Officer
mixed-class rows
349,469
mixed-class rows
$2,876,721 11 Sep 2023
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.37%
309,779
$2,530,895 31 Mar 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.37%
308,841
$2,523,231 31 Mar 2024
13F
Woodline Partners LP
13F
Company
0.36%
293,622
$2,398,892 31 Mar 2024
13F
FMR LLC
13F
Company
0.35%
286,479
$2,340,534 31 Mar 2024
13F
Clearbridge Investments, LLC
13F
Company
0.34%
277,969
$2,271,006 31 Mar 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.33%
272,133
$2,223,327 31 Mar 2024
13F
TD ASSET MANAGEMENT INC
13F
Company
0.29%
238,846
$1,951,372 31 Mar 2024
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.27%
222,600
$1,818,642 31 Mar 2024
13F
Qube Research & Technologies Ltd
13F
Company
0.27%
221,222
$1,807,384 31 Mar 2024
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.26%
212,653
$1,737,375 31 Mar 2024
13F
Amundi
13F
Individual
0.3%
248,080
$1,729,118 31 Mar 2024
13F
Nan Fung Group Holdings Ltd
13F
Company
0.25%
204,939
$1,674,352 31 Mar 2024
13F
Tanya Lewis
3/4/5
Chief Dev. Op. Officer
class O/S missing
135,293
$1,477,400 13 Jun 2023
Jean M. Franchi
3/4/5
Chief Financial Officer
class O/S missing
128,748
$1,405,928 16 May 2023
ExodusPoint Capital Management, LP
13F
Company
0.21%
171,015
$1,397,000 31 Mar 2024
13F
Bank of New York Mellon Corp
13F
Company
0.2%
162,755
$1,329,708 31 Mar 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.19%
161,053
$1,316,000 31 Mar 2024
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.19%
158,291
$1,293,237 31 Mar 2024
13F

Institutional Holders of Replimune Group, Inc. - Common Stock, $0.001 par value (REPL) as of Q2 2024

As of 30 Jun 2024, Replimune Group, Inc. - Common Stock, $0.001 par value (REPL) was held by 148 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 70,902,356 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, Redmile Group, LLC, FCPM III SERVICES B.V., BlackRock Inc., MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, Omega Fund Management, LLC, Atlas Venture Life Science Advisors, LLC, and MORGAN STANLEY. This page lists 148 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
147
Q2 2024 holders
148
Holder diff
1
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 Value $ Q2 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .